Search - tctmd.com

Displaying 1 - 5 of 5

Sort: Relevancy | Date

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

June 09, 2022

FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns

News Daily News

FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns

February 14, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2020

January 31, 2020

News Daily News

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

January 14, 2020

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

August 20, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.